Preoperative clinical application of human fibrinogen in patients with acute Stanford type A aortic dissection: A single‐center retrospective study

Jiahui Li,Qingsong Wu,Mirong Tang,Yue Shen,Zhihuang Qiu,Xiaodong Chen,Xingfeng Chen,Liangwan Chen
DOI: https://doi.org/10.1111/jocs.16759
IF: 1.778
2022-07-26
Journal of Cardiac Surgery
Abstract:Objective To evaluate the perioperative clinical efficacy of preoperative human fibrinogen treatment in patients with acute Stanford type A aortic dissection (ATAAD). Methods Data of 159 patients with ATAAD who underwent emergency surgical treatment in our hospital from January 2019 to December 2020 were retrospectively analyzed. Patients were divided into two groups according to whether human fibrinogen was administered before surgery: patients in group A received fibrinogen before surgery, while those in group B did not. The preoperative clinical data, surgical data, postoperative data, complications related to the coagulation function, and mortality of the two groups were compared and analyzed. Results The in‐hospital mortality was similar in the two groups (2.9% vs. 9.3%, p = .122). However, group A had a significantly shorter operation time (279.24 ± 39.03 vs. 298.24 ± 45.90, p = .008), lower intraoperative blood loss (240.48 ± 96.75 vs. 353.70 ± 189.80, p
surgery,cardiac & cardiovascular systems
What problem does this paper attempt to address?